Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-19

Clinical Trial Update: An Bioequivalence Study of Loxoprofen Sodium Patches in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of Loxoprofen Sodium Patch in healthy volunteers, not yet recruiting, sponsored by Frontier Biotechnologies Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loxoprofen Sodium Patch (loxoprofen sodium)

Snippet

Sponsor: Frontier Biotechnologies Inc. | Conditions: Osteoarthritis, Muscle Pain | Phase 1 | Status: NOT_YET_RECRUITING